表紙
市場調查報告書

微創脊椎壓迫性骨折 (MIVCF) 治療的全球市場分析

Minimally Invasive Vertebral Compression Fracture Treatments | Medtech 360 | Market Insights | Global

出版商 Decision Resources Group - Medtech 商品編碼 192335
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
微創脊椎壓迫性骨折 (MIVCF) 治療的全球市場分析 Minimally Invasive Vertebral Compression Fracture Treatments | Medtech 360 | Market Insights | Global
出版日期: 2019年03月25日內容資訊: 英文
簡介

全球微創脊椎壓迫性骨折 (MIVCF) 治療市場,由於人口高齡化和肥胖症患者增加等要素,預計今後也將持續擴大趨勢。還有新產品的認證和上市,高性能、高價格的治療技術引進等好消息相繼出現,預計抵銷各種負面因素 (醫療費償付額的降低等) 。

本報告提供全球微創脊椎壓迫性骨折 (MIVCF) 治療的市場相關分析,整體市場結構和趨勢預測 (今後10年份),各領域詳細趨勢,市場競爭狀況 (主要企業的市場佔有率等),主要的推動及阻礙市場要素等相關調查。

摘要

摘要整理

更新履歷

微創脊椎壓迫性骨折 (MIVCF) 治療市場

  • 市場概要
    • 美國,歐洲,亞太地區
  • 市場定義
  • 市場預測資料
  • 競爭概要
  • 市場佔有率
  • 競爭要素與策略
    • 臨床資料
    • 醫療費償付
    • 價格策略和購買選擇
    • 企業合併、收購 (M&A),事業聯盟
    • 醫生訓練/行銷
    • 領先者利益
    • 產品改良,技術開發
  • 市場動靜

椎體形成市場

  • 市場概要
  • 市場定義
  • 市場預測資料
  • 競爭概要
  • 市場佔有率
  • 競爭要素與策略

脊椎增強市場

  • 市場概要
  • 市場定義
  • 市場預測資料
  • 競爭概要
  • 市場佔有率
  • 競爭要素與策略

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: M360VE0007

The global MIVCF treatment device market will be driven mainly by the growing aging and obese population across the globe. Furthermore, new product launches and increasing adoption of advanced premium-priced technologies will help overcome obstacles such as unfavorable reimbursement environments. Therefore, the market will see moderate growth through 2027.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for MIVCF treatment devices in the global region across a 10-year period.

Large MNCs continue to dominate the moderately expanding global MIVCF treatment market, bolstering share through mergers and acquisitions and product launches.

Which competitors lead the MIVCF treatment market globally, and what factors contribute to their success in this space?

What strategies can local and international players implement to capture share in the global MIVCF treatment market?

What types of mergers and acquisitions have occurred in recent years, and how do they affect market shares?

There have been few product launches in the vertebroplasty market.

What factors are contributing to a lack of manufacturer focus in the vertebroplasty market?

What can companies competing in the vertebroplasty market do to maintain or gain shares?

Several studies and reports are showing vertebroplasty and vertebral augmentation to be not beneficial in treating VCFs.

What are physicians' opinion on this?

How have these findings affected the global MIVCF treatment market?

Author(s): Monica Lin, BSc

image1

Monica Lin is an analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, focusing on the sports medicine, spinal implant, vertebral compression fracture treatment, and skin replacement and substitute markets. Monica holds an Honors Bachelor's degree in Life Physics and Economics from the University of Waterloo.


Table of Contents

Global

Abstract

Executive Summary

  • Market Highlights
  • Competitive Highlights
  • Market Developments
  • Geographies Covered
  • Procedures Covered
  • Products Covered

Key Report Updates

MIVCF Treatment Market

  • Market Highlights
  • US
  • Europe
  • Asia Pacific
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies
  • Clinical Data
  • Reimbursement
  • Pricing Strategies and Purchasing Options
  • Mergers, Acquisitions, and Partnerships
  • Physician Training and Marketing
  • First-Mover Advantage
  • Product Improvements and Innovations
  • Market Developments

Vertebroplasty Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Vertebral Augmentation Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Appendix

  • Abbreviations
  • Bibliography